Navigation Links
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Date:10/29/2009

me taxes 29,907 10,852 (7) 40,759 Net income $49,422 $24,829 $74,251 Diluted earnings per share $0.42 -- $0.63 Diluted weighted average shares 117,643 -- 117,643

Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations:

  1. To exclude amortization of commercial intangible assets related to marketed products of $16,738 and the impact of an Indevus inventory step-up recorded as part of acquisition accounting of $5,879.
  2. To exclude certain separation payments.
  3. To exclude upfront and milestone payments to partners.
  4. To exclude Indevus transaction and separation costs of $2,484 as well as the impact, under purchase accounting, of a gain recorded to reflect the change in the company's current estimate of fair value, in accordance with GAAP, of the contingent consideration associated with the Indevus acquisition of ($22,690).
  5. To exclude additional interest expense as a result of adopting FSP APB 14-1 of $3,958 and to exclude amortization of the premium on debt acquired from Indevus of ($228).
  6. To exclude changes in fair value of financial instruments, net of ($298) as well as the gain on the extinguishment of a portion of the debt acquired from Indevus of $4,025.
  7. To reflect the cash tax savings resulting from the Indevus acquisition as well as the tax effect of the pre-tax adjustments above at applicable tax rates. 
    Three Months Ended        Actual
     September 30, 2008      Reported
     (unaudited)              (GAAP)   Adjustments        Adjusted

    Total Revenues           $316,768            $        $316,768
    Costs and expenses:
      Cost of revenues         71,027       (8,878)  (1)    62,149
      Selling, general and
       administrative         116,249       (3,583)  (2)   112,666
      Research a
'/>"/>
SOURCE  Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 

Related medicine technology :

1. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
2. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
4. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
5. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
6. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
7. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
8. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
9. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
10. BioMarin Acquires Huxley Pharmaceuticals, Inc.
11. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...
(Date:5/21/2013)... , May 21, 2013   Accuray ... today the publication of study results involving hundreds ... Robotic Radiosurgery System, the most widely used form ... study followed 304 patients for a median of ... and found that 97 percent of patients with ...
(Date:5/21/2013)... 21, 2013  Healthcare organizations expanding into emerging markets ... , India and ... no shortcuts.  This is proving particularly challenging, considering the ... must change the dialogue around BRIC, as it is ... and building regional partnerships to build a sustainable business. ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4
... MIRAGE, Calif., March 27 In the medical,community at ... attacks kill,and destroy cells in the heart muscle. Multiple ... stimulate the heart to repair,itself after an individual suffers ... The Weil Institute of Critical Care Medicine, located in ...
... Discovery Support Program, HAMBURG, Germany and ... (Frankfurt Stock Exchange: EVT) announced today that ... Japan) signed a new drug,discovery agreement targeting ... collaboration applies Evotec,s proprietary fragment-based drug,discovery platform, ...
Cached Medicine Technology:Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack 2Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 2Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 3
(Date:5/21/2013)... risk of sudden infant death syndrome (SIDS) is five ... new study finds. British researchers noted that bed-sharing ... not drink, use illegal drugs or smoke. They advised ... of infant death in developed countries, would drop dramatically ... In the United States, all parents are advised to ...
(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...
(Date:5/21/2013)... 2013 Residents in St. Petersburg, FL ... now that Dr. David Sherberg, DMD, has joined Coast ... Dr. Sherberg provides preventive, restorative and cosmetic dentistry to ... friendly team provide a wide variety of services ... canal therapy, crowns, bridges, dentures, dental implant restorations, veneers, ...
(Date:5/21/2013)... TheBeautyPlace.com helps brides to breathe a little easier ... Kit including all the essentials a glowing bride or ... Wedding Day. , TheBeautyPlace.com features Wedding Day essentials to ... Day. Flowers blooming and warmer weather indicates the springtime, ... Memorial Day to October, brides to be can finally ...
(Date:5/21/2013)... Dr. Francine Kaufman , inventor of Extend ... patients in the 1980s: It weighed several pounds and was jokingly ... it could only be used in the hospital setting. , The ... the advantages are greater as well. The insulin pump is now ... often on a belt or a pocket. It delivers fast-acting insulin ...
Breaking Medicine News(10 mins):Health News:Bed-Sharing Raises SIDS Risk Fivefold, Study Finds 2Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 3Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4
... A group ... Jackson Healthcare. The Hospital Charitable Service Awards have been created to find and celebrate ... ... A group of senior healthcare executives have joined forces to launch a new awards program ...
... BOSTON (May 25, 2010) Longtime environmental health ... the carcinogenic effects of endocrine-disrupting chemicals (EDCs), ubiquitous ... In a review article published online May 25 ... express the need for more complex strategies for ...
... a new influenza vaccine that brings science one step closer ... for seasonal flu shots. The new findings can be ... first online, open-access journal published by the American Society for ... narrow range of influenza virus strains," said Peter Palese, Ph.D., ...
... Suggestions include ,presumed consent, and priority for those who pledge ... transplants save thousands of lives every year, but many more ... of organs. While proposals to increase the supply have ... -- or even if they should be tried at all. ...
... ... and earn money for college, by entering the B’nai B’rith International Diverse Minds Youth ... grade-schoolers about tolerance and diversity. The winners take home $5,000 college scholarships and will ... ...
... Arnhem -- On 8 May an editorial about the Reduction ... H. Schrder and Monique J. Roobol was published in the ... of the European Association of Urology (EAU). The ... 1, 2010 in the New England Journal of Medicine ...
Cached Medicine News:Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 2Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 3Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 4Health News:Endocrine-disrupting chemicals pose cancer risk 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 3Health News:High School Students Well-Schooled In Diversity: Teen Winners of Book Writing Contest Earn College Scholarships and Have Entries Published 2Health News:European Urology: Editorial about REDUCE trial underlines value of dutasteride 2
... ago, Zyderm® and Zyplast® injectable collagen implants ... for smoothing facial lines, wrinkles and scars ... supplement the skins natural collagen, require minimal ... more than one million people worldwide have ...
... Captique is a non-animal stabilized ... newest HA filler to enter the ... correction of moderate to severe facial ... folds). Captique is injected just under ...
... Radiesse brings you into the new ... can now offer your patients immediate, long-term ... and flexibility. This injectable filler offers superior ... cosmetic and reconstructive treatments. Long-lasting, Radiesse saves ...
The HEMOCHRON Model 401 is a portable, single-well whole blood coagulation monitoring instrument. The 401 provides on-screen plasma equivalent PT and APTT test results....
Medicine Products: